Just been looking at some of the warren buffett stocks that are still sitting in Berkshire's portfolio, and there's definitely some interesting plays here worth digging into.

So here's what caught my attention. American Express has become Berkshire's second-biggest holding at just over $47 billion, and honestly it's gotten beaten down pretty hard lately. Down nearly 20% from December highs because everyone's freaking out about consumer debt levels and whether people can actually pay their credit card bills. Fair concern on the surface - U.S. household debt hit a record $18.8 trillion with delinquencies near a decade high at 4.8%. But here's the thing that most people are missing: Amex isn't your typical credit card company. Their customer base skews wealthy, and luxury spending from their cardholders actually grew 15% year-over-year last quarter. That's almost double the 8% growth in total billed business. So while everyone's panicking about the average consumer, Amex's actual client base is still spending like it's going out of style. This pullback might be the best entry point you'll get.

Then there's Constellation Brands. Yeah, the Corona and Modelo play hasn't exactly printed money since Berkshire bought in late 2024. Shares are down, and alcohol consumption in the U.S. is at a multidecade low of 54% according to Gallup. Sounds bad, right? But I think people are overlooking something crucial here. The beverage industry is cyclical as hell. People cut back on spending during rough economic periods, but demand always comes roaring back once confidence returns. Plus, the company's been quietly restructuring - divested some lower-margin wine brands that were more headache than help. New CEO Nicholas Fink coming in should shake things up too. These warren buffett stocks in the consumer space need patience, but Constellation feels like it's setting up for a turnaround.

Now, the one I'd actually stay away from? DaVita. This is where you see Buffett's patience wearing thin. He's been holding this kidney dialysis company since 2011, but the fundamentals have deteriorated significantly. Revenue is growing modestly at 5% year-over-year through the first three quarters of 2025, but net income dropped 17%. That's the real story. It's a perfect example of the healthcare industry's broader struggle right now - reimbursement pressures, rising costs, and no clear relief in sight. Tellingly, Berkshire started scaling out of this position early last year after mostly leaving it alone for over a decade. When Buffett starts quietly exiting a holding, that's usually worth paying attention to.

The broader point with these warren buffett stocks is that his fingerprints are still all over Berkshire's moves, even though he's stepped back from day-to-day decisions. Some of these positions look genuinely attractive at current levels if you've got the patience to wait out the noise.